HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A L Thomas Selected Research

pegamotecan

1/2009A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A L Thomas Research Topics

Disease

6Neoplasms (Cancer)
01/2017 - 12/2000
2Stomach Neoplasms (Stomach Cancer)
01/2009 - 10/2001
2Adenocarcinoma
01/2009 - 10/2001
2Colorectal Neoplasms (Colorectal Cancer)
04/2007 - 04/2005
2Neutropenia
08/2006 - 07/2002
1Body Weight (Weight, Body)
01/2017
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2017
1Disease Progression
01/2009
1Fatigue
08/2006
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
08/2006
1Rheumatic Diseases (Rheumatism)
02/2005
1Fever (Fevers)
07/2002
1Breast Neoplasms (Breast Cancer)
07/2002
1Cardiotoxicity
07/2002
1Acquired Hyperostosis Syndrome (SAPHO Syndrome)
02/2002
1Cryptosporidiosis
01/2002
1Hypersensitivity (Allergy)
11/2001
1Myalgia
12/2000
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2000
1Pneumonia (Pneumonitis)
12/2000

Drug/Important Bio-Agent (IBA)

2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017 - 04/2007
2Fish OilsIBA
01/2017 - 01/2017
2vatalanib (PTK787)IBA
04/2007 - 04/2005
2Pharmaceutical PreparationsIBA
07/2002 - 11/2001
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017
1LipidsIBA
01/2017
1Epirubicin (Ellence)FDA LinkGeneric
01/2017
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2017
1Capecitabine (Xeloda)FDA Link
01/2017
1EmulsionsIBA
01/2017
1pegamotecanIBA
01/2009
1Irinotecan (Camptosar)FDA LinkGeneric
01/2009
1CamptothecinIBA
01/2009
1Topoisomerase I InhibitorsIBA
01/2009
1Leucovorin (Folinic Acid)FDA Link
04/2007
1Angiogenesis InhibitorsIBA
04/2007
1Fluorouracil (Carac)FDA LinkGeneric
04/2007
1Carboplatin (JM8)FDA LinkGeneric
08/2006
1soblidotin (TZT 1027)IBA
08/2006
1Biomarkers (Surrogate Marker)IBA
05/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2005
1Biological ProductsIBA
04/2005
1Tyrosine Kinase InhibitorsIBA
04/2005
1Methotrexate (Mexate)FDA LinkGeneric
02/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2004
1Daunorubicin (Cerubidine)FDA LinkGeneric
07/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2002
1Pamidronate (Aredia)FDA LinkGeneric
02/2002
1Cryptosporidium oocyst wall proteinIBA
01/2002
1Penicillins (Penicillin)FDA Link
11/2001
1CytokinesIBA
11/2001
1beta Lactam AntibioticsIBA
11/2001
1Immunoglobulin E (IgE)IBA
11/2001
1liposomal doxorubicin (Doxil)FDA Link
10/2001
1GemcitabineFDA Link
12/2000
1Paclitaxel (Taxol)FDA LinkGeneric
12/2000
1marimastatIBA
12/2000

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2017 - 08/2001
2Therapeutics
05/2006 - 10/2001
1Intravenous Infusions
01/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2009
1Drug Tapering
07/2002